These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 29065135)
1. The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent. Lei S; Ding Y; Fu Y; Wu S; Xie X; Wang C; Liang H PLoS One; 2017; 12(10):e0184501. PubMed ID: 29065135 [TBL] [Abstract][Full Text] [Related]
3. SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status. Al-Katib AM; Sun Y; Goustin AS; Azmi AS; Chen B; Aboukameel A; Mohammad RM J Hematol Oncol; 2009 Feb; 2():8. PubMed ID: 19220884 [TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107 [TBL] [Abstract][Full Text] [Related]
5. Feedback autophagy activation as a key resistance factor of Ku-0060648 in colorectal cancer cells. Mao M; Liu Y; Gao X Biochem Biophys Res Commun; 2017 Sep; 490(4):1244-1249. PubMed ID: 28676397 [TBL] [Abstract][Full Text] [Related]
6. TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis. Ashimori N; Zeitlin BD; Zhang Z; Warner K; Turkienicz IM; Spalding AC; Teknos TN; Wang S; Nör JE Mol Cancer Ther; 2009 Apr; 8(4):893-903. PubMed ID: 19372562 [TBL] [Abstract][Full Text] [Related]
7. Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells. Wang H; Zhang Z; Wei X; Dai R J Ovarian Res; 2015 Feb; 8():3. PubMed ID: 25823945 [TBL] [Abstract][Full Text] [Related]
8. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. Wang Z; Song W; Aboukameel A; Mohammad M; Wang G; Banerjee S; Kong D; Wang S; Sarkar FH; Mohammad RM Int J Cancer; 2008 Aug; 123(4):958-66. PubMed ID: 18528859 [TBL] [Abstract][Full Text] [Related]
9. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543. Ju T; Gao D; Fang ZY Biochem Biophys Res Commun; 2016 Feb; 470(3):728-734. PubMed ID: 26775841 [TBL] [Abstract][Full Text] [Related]
10. Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells. Zhijun H; Shusheng W; Han M; Jianping L; Li-Sen Q; Dechun L Tumour Biol; 2016 Aug; 37(8):10257-67. PubMed ID: 26831668 [TBL] [Abstract][Full Text] [Related]
11. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway. Wang Z; Azmi AS; Ahmad A; Banerjee S; Wang S; Sarkar FH; Mohammad RM Cancer Res; 2009 Apr; 69(7):2757-65. PubMed ID: 19318573 [TBL] [Abstract][Full Text] [Related]
13. Preclinical study of cinobufagin as a promising anti-colorectal cancer agent. Lu XS; Qiao YB; Li Y; Yang B; Chen MB; Xing CG Oncotarget; 2017 Jan; 8(1):988-998. PubMed ID: 27894091 [TBL] [Abstract][Full Text] [Related]
14. Pre-clinical characterization of PKC412, a multi-kinase inhibitor, against colorectal cancer cells. Li JP; Huang ZJ; Lu XS; Zhou YC; Shao Y; He XP; Chen SR; Wang DD; Qin LS; Sun WH Oncotarget; 2016 Nov; 7(47):77815-77824. PubMed ID: 27780925 [TBL] [Abstract][Full Text] [Related]
15. Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings. Lu PH; Chen MB; Ji C; Li WT; Wei MX; Wu MH Oncotarget; 2016 Jul; 7(29):45889-45900. PubMed ID: 27322552 [TBL] [Abstract][Full Text] [Related]
16. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms. Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222 [TBL] [Abstract][Full Text] [Related]
17. Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo. Chen C; Kuo YH; Lin CC; Chao CY; Pai MH; Chiang EI; Tang FY PLoS One; 2020; 15(5):e0232832. PubMed ID: 32401800 [TBL] [Abstract][Full Text] [Related]
18. NPC-26 kills human colorectal cancer cells via activating AMPK signaling. Zhao Z; Feng L; Wang J; Cheng D; Liu M; Ling M; Xu W; Sun K Oncotarget; 2017 Mar; 8(11):18312-18321. PubMed ID: 28407688 [TBL] [Abstract][Full Text] [Related]
19. Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation. Zeitlin BD; Spalding AC; Campos MS; Ashimori N; Dong Z; Wang S; Lawrence TS; Nör JE Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):879-87. PubMed ID: 20675079 [TBL] [Abstract][Full Text] [Related]
20. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo. Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]